Total Funding
54
48
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115009
Rna Diagnostics is a Canadian company with a patented platform technology providing real-time cancer therapy guidance.
- Past Role: Luminex, Senior Vice President, Research & Development
- Amadeo Parissenti: Chief Scientific OfficerPast Role: University of Toronto, Postdoctoral Fellow
About the Company
Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.
